Patents by Inventor Jill Helms

Jill Helms has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180000893
    Abstract: Methods and compositions are provided for enhancing dentin production, and for delivering a lipophilic agent to pulp tissue of a tooth of an individual. In some cases, a subject method includes a step of administering to the pulp of a tooth of an individual, a Wnt stimulating composition that includes a Wnt stimulator agent, at a dose sufficient to enhance the production of dentin by the pulp. In some cases, a subject method includes a step of contacting exposed dentin of a tooth with a composition that includes a lipophilic agent inserted in the non-aqueous phase of a lipid structure (e.g., whereby the lipophilic agent penetrates the dentin to the underlying pulp tissue). Kits are also provided for practicing the methods of the disclosure.
    Type: Application
    Filed: December 28, 2015
    Publication date: January 4, 2018
    Inventors: Jill Helms, Daniel J. Hunter
  • Publication number: 20170056556
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Application
    Filed: March 7, 2016
    Publication date: March 2, 2017
    Inventors: Jill Helms, Girija Dhamdhere
  • Publication number: 20160310424
    Abstract: Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.
    Type: Application
    Filed: October 2, 2014
    Publication date: October 27, 2016
    Inventors: Jill Helms, Girija Dhamdhere
  • Patent number: 9301980
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: April 5, 2016
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIO
    Inventors: Jill Helms, Girija Dhamdhere
  • Publication number: 20150050249
    Abstract: The present invention concerns the enhancement of the osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide.
    Type: Application
    Filed: July 16, 2014
    Publication date: February 19, 2015
    Inventors: Jill Helms, Girija Dhamdhere
  • Publication number: 20140371151
    Abstract: Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.
    Type: Application
    Filed: July 22, 2014
    Publication date: December 18, 2014
    Inventor: Jill Helms
  • Patent number: 8809272
    Abstract: Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: August 19, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventor: Jill Helms
  • Publication number: 20120115788
    Abstract: Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.
    Type: Application
    Filed: September 9, 2011
    Publication date: May 10, 2012
    Inventor: Jill Helms
  • Publication number: 20080226707
    Abstract: Methods and compositions are provided for the therapeutic use of Wnt proteins, where the Wnt protein is inserted in the non-aqueous phase of a lipid structure. In some embodiments the Wnt protein is presented in its active conformation on an outer liposome membrane or micelle. Pharmaceutical compositions of the present invention can be administered to an animal for therapeutic purposes. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.
    Type: Application
    Filed: March 5, 2008
    Publication date: September 18, 2008
    Inventors: Jill Helms, Roeland Nusse, Jaebeom Kim, Philipp Leucht